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Hydatid disease is a parasitosis caused by Echinococcus gran-
ulosus. It has been known since the time of Hippocrates and is
still an endemic disease in some regions of the world, parti-
cularly in South America, North Africa, Asia and Australia.1
The incidence of hydatid cysts is 18—20/100 000 in Turkey,
one of the endemic countries.2
A hydatid cyst may develop in almost any part of the body,
and in adults the lung is the second most common target for
hydatid disease after the liver.2 A subcutaneous cyst in the
proximal thigh and breast involvement are very rare. We
describe herein a case presenting with subcutaneous hydatid
disease of the thigh associated with breast and lung involve-
ment.
A 32-year-old woman was admitted to our clinic with
complaints of thigh and left-sided chest pain. Laboratory
tests were normal. Physical examination revealed a painful
mass, palpated subcutaneously on the lateral thigh, over
the left vastus lateralis muscle. The range of motion of the
left hip and knee were full and painless. A painless mass
lesion was detected at the 9 o’clock position in the left
breast. The patient had no complaints and no history of
breast disease.
Computerized tomography (CT) scans of the thorax
showed a solitary pulmonary nodule, 1 cm in diameter, in
the left inferior lobe. CTof the brain and abdomen revealed
no other organ involvement. Magnetic resonance imaging
(MRI) demonstrated a well-circumscribed subcutaneous cyst(size 4  2.5 cm) in the proximal one third of the lateral
thigh over the fascia lata (Figure 1). Ultrasonography of the
left breast revealed a cystic lesion measuring 1 cm in
diameter.
The patient underwent single-stage surgery. Thefirst step
of the surgical procedure was excision of the cyst in the
breast. The second step involved cystectomy plus pericys-
tectomy performed on the lung lesion via a left poster-
olateral thoracotomy, and pericystectomy performed on
the thigh lesion via a left lateral longitudinal incision. The
last two surgical interventions were carried out with the
patient in a lateral decubitus position. The diagnosis of
hydatid cyst was confirmed by histopathological examina-
tion (Figure 2); scolices were seen in histopathologic section
of the hydatic cyst. The patient was given a course of
medical treatment (albendazole 10 mg/kg/day) and after
6 months of follow-up, there was no evidence of recurrent
disease.
Hydatid disease is still a major health problem that
affects both humans and animals in our country. Human
hydatid cyst disease caused by E. granulosus can develop
in almost any organ or tissue by hematogenous dissemina-
tion.2,3 The liver is the most frequently involved organ (50—
60%), followed by the lung (10—30%). Soft-tissue echinococ-
cosis occurs in 2.3% of cases reported from endemic areas
and is usually associated with other solid organ involve-
ment.3,4
Musculoskeletal echinococcosis is observed in 1—5.4% of
all cases of hydatid disease.5—7 Cases of musculoskeletal
hydatid cysts have been reported involving the supraspina-
tus, pectoralis major, brachial biceps, thigh and chest wall
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Figure 1 MRI view of a primary subcutaneous hydatic cyst in
the proximal thigh.muscles.8,9 However, there have been very few reports of
thigh involvement.10—13 In the series of Safioleas et al., thigh
involvement was seen in only 0.37% of 272 cases of hydatid
cysts.14 A hydatid cyst of the breast is rare even in endemic
regions, accounting for 0.27% of hydatid disease cases.15Figure 2 (a) Macroscopic view of the subcutaneous cyst from
the proximal thigh. (b) The microphotograph reveals a fibrous
capsule, cuticular membrane (white arrow), germinative mem-
brane and a daughter vesicle (black arrow) of hydatid cyst
adjacent to adipose tissue (H&E  40).Mammography and ultrasonography are not entirely help-
ful in the differential diagnosis of a hydatid cyst of the
breast.15 Fine-needle aspiration has diagnostic value but
contamination risk should be kept in mind when this is
performed in cases of hydatid disease. Serological tests
may not always be positive, as in this case. MRI can ade-
quately demonstrate most features of the hydatid cyst,16 and
ultrasound and CT are also helpful in making a preoperative
diagnosis. Total cyst excision is the treatment of choice, and
combination adjunctive chemotherapy with anthelmintics is
recommended to reduce the risk of dissemination during
surgery and to prevent recurrence.
If the pulmonary hydatid disease is complicated, it may
resemble other malignant and benign lesions of the lung.17 In
the current case, however, there was suspicion that the lung
lesion was a ruptured hydatid cyst because of the multiple
other organ involvement and the fact that this is an endemic
region. The diagnosis of complicated hydatid cyst was con-
firmed by histopathological examination.
Our case concerns multiple atypical involvement includ-
ing thigh, breast and lung. Coexistence of hydatid cysts in
these localizations has not been previously reported. This
case supports the overall opinion that hydatid cysts can be
located simultaneously in various tissues. Treatment con-
sists of the excision of the cyst and postoperative medical
treatment.
In conclusion, hydatid disease should be considered in the
differential diagnosis of all cystic lesions even if they are in
atypical locations, especially if they occur in Echinococcus
endemic regions.
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doi:10.1016/j.ijid.2007.01.004Imipenem-resistance in Klebsiella pneumoniae
in Malaysia due to loss of OmpK36 outer mem-
brane protein coupled with AmpC hyperpro-
duction
Carbapenems are frequently used to treat infections
caused by extended-spectrum b-lactamase (ESBL)-produ-
cing Klebsiella pneumoniae. Resistance to carbapenems in
K. pneumoniae is infrequent and may be due to production
of AmpC cephalosporinase combined with decreased outer
membrane permeability due to loss or alteration of porins.1
A second possible mechanism of resistance is production of
a b-lactamase that is capable of hydrolyzing carbapenems.
This includes the metallo-b-lactamases (MBLs) of class B
and the class A imipenem-hydrolyzing non-MBLs such as
KPC-1.2
In June 2004, an imipenem-resistant strain of K. pneu-
moniae (1/B37) was isolated from the blood culture of an
inpatient at the University of Malaya Medical Centre
(UMMC), Kuala Lumpur, Malaysia. We present a brief clinical
history of the patient and report our findings on the char-
acterization of the mechanism of resistance to imipenem in
the strain.
The patient, a 42-year-old woman who had undergone a
myeloablative allogeneic peripheral blood stem cell trans-
plant for acute myeloid leukemia, presented on day 22 post-
transplant with fever and abdominal pain. Her blood counts
were normal, with hemoglobin of 120 g/dl, white cell count
of 13.2  109/l with 83% neutrophils, and a platelet count of
146  109/l. A working diagnosis of septicemia with likelyacute graft-versus-host disease (GVHD) was made, and rou-
tine blood cultures and blood fungal cultures were carried
out. It was noted at this time that the site of the peripherally
inserted central catheter (PICC), which had been inserted
during the transplant, was inflamed; the catheter was
removed. Empirical treatment with intravenous imipenem,
vancomycin and methylprednisolone was started, and two
days later a triple lumen catheter was inserted. The blood
cultures for bacterial and fungal pathogens were negative.
She developed multiple macular rashes that became progres-
sively worse and the steroid dose was increased. Cyclosporin,
which had been instituted immediately after her transplant,
was then changed to intravenous tacrolimus. Intravenous
immunoglobulin was also given at this time and repeated
fortnightly. On day 28 post-transplant, in view of the
progressive and severe nature of the acute skin GVHD (stage
4), intravenous infliximab 600 mg weekly was instituted.
Earlier skin biopsy findings confirmed the diagnosis of acute
GVHD. Her fever settled and repeated blood cultures showed
no growth; vancomycin was stopped but imipenem was
continued. However, the skin GVHD progressively worsened
and antifungal and antiviral prophylaxis (fluconazole and
acyclovir) were started in view of her severe immunosup-
pressed state. A skin swab taken at this time grew Proteus spp
and Acinetobacter baumannii, and intravenous Unasyn1 was
added. A day later, small skin nodules suggestive of systemic
fungal infection were noted on her back and neck folds.
Fluconazole was stopped and intravenous amphotericin B
was commenced. Following this the patient developed high
fever with new findings in her lungs. Intravenous vancomycin
was added to the antimicrobial regimen. A septic workout
